Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

Our Research Accomplishments

1/10/20

Raymond P. Dannenhoffer, PhD, associate dean for support services, has received the 2019 Newman Award from UB Catholic, the university’s Catholic Campus Ministry.

1/7/20

The Participate in Research portal is a new online tool that lists and updates every active clinical trial throughout the University at Buffalo.

1/6/20

A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).

1/6/20

Third-year medical students took part in a seminar designed to enhance their awareness and understanding of different types of spirituality.

12/19/19

UB HEALS, a street medicine outreach initiative of the Jacobs School of Medicine and Biomedical Sciences, held a foot clinic Dec. 5 for Buffalo’s homeless population.

12/18/19

Jerrold C. Winter, PhD, professor of pharmacology and toxicology, is the author of an entertaining and informative new book, “Our Love Affair with Drugs: The History, the Science, the Politics,” published by Oxford University Press.

12/17/19

Otolaryngology surgeons and residents, facial plastic surgeons and other health care personnel got to experience cutting edge technology and techniques during Rhinofest 2019, which took place this fall at the Jacobs School of Medicine and Biomedical Sciences building.

12/13/19

The New York State Area Health Education Center System (AHEC), based in the Department of Family Medicine, has received two federal grants for programs aimed at addressing the opioid epidemic.

12/5/19

Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.

Recent Publications

Recent Research Funding

  • Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
  • Bioinformatic Approaches for Understanding Macrophage Plasticity and Microbiome in Oral Diseases. Keith Kirkwood (Principal Investigator). national Institutes of Health. $94,393. 4/1/2020-3/1/2021.
  • Keith Kirkwood (Co-Investigator). national Institutes of Health. $275,000. 4/1/2020-3/1/2022.
  • Mechanisms of Heat Sensing by Nociceptive Vanilloid Receptors. Feng Qin (Principal Investigator). NIH. $2,684,432. 4/1/2020-3/1/2025.